dextrothyroxine has been researched along with Eczema, Atopic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Egawa, S; Fukaya, S; Fukuyasu, A; Hayashi, K; Ishikawa, T; Kamata, M; Nagata, M; Tada, Y; Tanaka, T; Uchida, H | 1 |
Heymann, WR; Krakowski, AC; Senft, SC | 1 |
Barzilai, A; Baum, S; Enk, CD; Greenberger, S; Pavlotsky, F; Schwartz, E; Solomon, M | 1 |
Fraser, K | 1 |
Albert, F; Dombrowicz, D; Hacini-Rachinel, F; Jomard, A; Julia, V; Laoubi, L; Lenief, V; Nicolas, JF; Rossio, P; Rozières, A; Staels, B; Ulmann, L; Ventre, E; Vial, E; Vocanson, M | 1 |
Iijima, OT; Komatsu, Y; Matsumiya, T; Takahashi, H; Takeda, H | 1 |
6 other study(ies) available for dextrothyroxine and Eczema, Atopic
Article | Year |
---|---|
Newly developed erythema and red papules in the face and neck with detection of demodex during dupilumab treatment for atopic dermatitis improved by discontinuation of dupilumab, switching to upadacitinib or treatment with oral ivermectin: A report of two
Topics: Dermatitis, Atopic; Erythema; Exanthema; Humans; Ivermectin; Severity of Illness Index; Treatment Outcome | 2023 |
Demodex Folliculitis and Recent Dupilumab Administration.
Topics: Adolescent; Animals; Antibodies, Monoclonal, Humanized; Antiparasitic Agents; Child; Dermatitis, Atopic; Facial Dermatoses; Folliculitis; Humans; Immunomodulation; Ivermectin; Male; Mite Infestations; Mites | 2021 |
Late-onset onchocercal skin disease among Ethiopian immigrants.
Topics: Adolescent; Adult; Antiparasitic Agents; Child; Dermatitis, Atopic; Emigrants and Immigrants; Ethiopia; Female; Humans; Israel; Ivermectin; Male; Middle Aged; Onchocerciasis; Pruritus; Retrospective Studies; Young Adult | 2014 |
72nd annual meeting of the American Academy of Dermatology.
Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States | 2014 |
Topical ivermectin improves allergic skin inflammation.
Topics: Administration, Topical; Allergens; Animals; Antigens, Dermatophagoides; Cell Line; Cytokines; Dendritic Cells; Dermatitis, Atopic; Disease Models, Animal; Enzyme-Linked Immunospot Assay; Fragile X Mental Retardation Protein; Humans; Inflammation Mediators; Ivermectin; Lymphocyte Activation; Macrophages; Mice; Mice, Knockout; Receptors, Purinergic P2X4; T-Lymphocyte Subsets | 2017 |
Atopic dermatitis in NC/Jic mice associated with Myobia musculi infestation.
Topics: Animals; Dermatitis, Atopic; Disease Models, Animal; Drug Administration Routes; Genetic Predisposition to Disease; Immunoglobulin E; Insecticides; Ivermectin; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mite Infestations; Rodent Diseases; Treatment Outcome | 2000 |